Cogent Biosciences
COGT
73 hedge funds and large institutions have $299M invested in Cogent Biosciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
6% more funds holding
Funds holding: 69 → 73 (+4)
5% more capital invested
Capital invested by funds: $284M → $299M (+$15.4M)
1.06% more ownership
Funds ownership: 94.74% → 95.8% (+1.1%)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$10.9M |
| 2 |
CC
Commodore Capital
New York
|
+$4.18M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.68M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$2.51M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$1.75M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SAM
76
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$219K | -27,000 | Closed |
|
77
Jane Street
New York
| – | -$196K | -24,192 | Closed |
|
|
QSS
78
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | -$182K | -22,474 | Closed |
|
79
LPL Financial
San Diego,
California
| – | -$122K | -15,000 | Closed |
|
|
PHK
80
Point72 Hong Kong
Hong Kong
| – | -$12K | -1,508 | Closed |
|
81
Bank Julius Baer & Co
Zurich,
Switzerland
| – | -$1K | -123 | Closed |
|
COGT Hedge Fund Activity: Q3 2021 in Review
73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2021, worth a combined $299M — up 5.4% from $284M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new COGT positions and 9 closed out — a net gain of 5 holders — while 18 added to existing stakes and 19 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $10.9M. The largest seller was HHLR Advisors, exiting entirely with an estimated $8.11M sold.
- 73 institutional investors held Cogent Biosciences (COGT) as of Q3 2021, up from 69 in Q2 2021.
- Funds reported $299M of Cogent Biosciences stock for Q3 2021, up 5.4% quarter-over-quarter.
- 14 funds opened new Cogent Biosciences positions in Q3 2021 and 9 closed out, a net change of +5 holders.
- The largest Cogent Biosciences buyer in Q3 2021 was Vivo Capital, an estimated $10.9M added.
- The largest Cogent Biosciences seller in Q3 2021 was HHLR Advisors, an estimated $8.11M sold.
Based on aggregated 13F filings for Q3 2021.